SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-004303
Filing Date
2021-01-14
Accepted
2021-01-14 17:23:45
Documents
47
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 FROM 10-Q tm211977d1_10q.htm 10-Q 297397
2 EXHIBIT 31.1 tm211977d1_ex31-1.htm EX-31.1 12383
3 EXHIBIT 31.2 tm211977d1_ex31-2.htm EX-31.2 13257
4 EXHIBIT 32.1 tm211977d1_ex32-1.htm EX-32.1 5410
5 EXHIBIT 32.2 tm211977d1_ex32-2.htm EX-32.2 5457
  Complete submission text file 0001104659-21-004303.txt   2373576

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rvph-20201130.xml EX-101.INS 398479
7 XBRL TAXONOMY EXTENSION SCHEMA rvph-20201130.xsd EX-101.SCH 30682
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvph-20201130_cal.xml EX-101.CAL 19274
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20201130_def.xml EX-101.DEF 90146
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20201130_lab.xml EX-101.LAB 196142
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20201130_pre.xml EX-101.PRE 183415
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38634 | Film No.: 21529680
SIC: 2834 Pharmaceutical Preparations